While rhabdomyolysis has previously been reported after several months of tirzepatide therapy, the present case is notable for the onset of this adverse effect following a single supratherapeutic dose ( In conclusion, the underlying pathophysiological mechanism remains uncertain
However, increasing data suggest that the pronounced weight loss with GLP-1 RAs may be accompanied by a decrease in SM mass
When semaglutide binds to GLP-1 receptors, it triggers a cascade of signals that reduce food intake, increase energy expenditure, and improve blood sugar stability
Brand companies therefore monitor PTAB petition activity against their PTE-extended patents with extreme care, often filing patent owner preliminary responses that challenge the petitioners standing and the quality of the prior art presented
Psychopharmacology, 156 (4), 481484